CDC this week raised its monkeypox alert to "level 2," encouraging people to practice certain safety precautions. However, a lack of information on the virus, including whether it may rarely be transmitted via aerosols, has caused public confusion and may impact efforts to limit the spread of the outbreak.
With additional Covid-19 response funding stalled in Congress, the White House on Wednesday announced it is cutting funding from some Covid-19 response areas in order to prioritize acquiring more vaccines.
Moderna on Wednesday released preliminary data on its omicron-specific coronavirus vaccine, calling it the company's "lead candidate" to serve as a booster shot this fall—but it is still unclear how effective the shot will be against the current subvariant strains spreading in the United States.
Almost 75% of insured Americans said they could easily access the mental health care they needed, according to a new survey by AHIP—but some patients who receive mental health care through their primary care physicians are seeing their claims denied, leaving them "with the short end of the stick."
After New York Times writer Melinda Wenner Moyer's daughter tested positive for the coronavirus, she assumed the whole family would "finally" get Covid-19. However, no one else in the family tested positive—even after they started experiencing "classic" Covid-19 symptoms.
The Federal Trade Commission voted unanimously to launch an investigation into the nation's largest pharmacy benefit managers, in today's bite-sized hospital and health industry news from the District of Columbia, Florida, and Texas.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.